loader
Please Wait
Applying Filters...

CSBio CSBio

X

Looking for Poly L Lactide? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 Nomisma Healthcare (2)

filter

01 India (2)

Close
4

Applications:

PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly L Lactide

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

PLLA

LM Application #LearnMore

Applications:

PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

Ingredient(s): Poly L Lactide

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY